Drawing for NUCLEAI

USPTO serial 79394242

NUCLEAI

Reviewed by CopyMark Law Group

Status 654
Filing date
Status date
Registration date
—
Examiner
CARROLL, DORITT
Law office
TMO LAW OFFICE 116

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NUCLEAI?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Robyn Lederman

Robyn Lederman Brooks Kushman P.C.150 W. Second Street, Suite 400NRoyal Oak, MI 48067United States

Goods and services

ClassDescriptionStatusFirst use
042Development and testing of software, namely, of methods and algorithms for use in software; software as a service featuring artificial intelligence software for use in drug research and development, clinical trials, biomarker research and development, translational research and development, diagnostic testing, clinical testing, and clinical diagnostics; biological research; clinical research in the field of digital pathology; medical research; scientific research in the nature of conducting clinical trials for others; providing medical and scientific research information about the results of clinical trials for pharmaceuticals; providing medical and scientific research information about the results of clinical trials for pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing online non-downloadable computer software platforms for scientific research and clinical diagnosticsACTIVE—
044Medical pathology services; pathological testing for diagnostic or research or treatment purposes; medical analysis for diagnostic or treatment purposes provided by medical laboratories; remote monitoring of medical data for medical treatment; medical laboratory analysis services relating to the treatment of persons; medical analysis services relating to the treatment of patients; medical analysis services relating to the treatment of persons provided by medical laboratories; providing information in the field of cancer prevention, screening, diagnosis and treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 14, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 16, 2026RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Oct 10, 2025OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Sep 24, 2025OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 24, 2025OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Aug 18, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 8, 2025RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Feb 6, 2025GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Feb 6, 2025GNSLLETTER OF SUSPENSION E-MAILED—
Feb 6, 2025CNSLSUSPENSION LETTER WRITTEN—
Jan 16, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 16, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 16, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 26, 2024RFNTREFUSAL PROCESSED BY IB—
Oct 7, 2024RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Oct 7, 2024RFRRREFUSAL PROCESSED BY MPU—
Oct 3, 2024RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Oct 2, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 22, 2024DOCKASSIGNED TO EXAMINER—
May 7, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
May 7, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 25, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance